These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30885023)

  • 1. Boron's neurophysiological effects and tumoricidal activity on glioblastoma cells with implications for clinical treatment.
    Altinoz MA; Topcu G; Elmaci İ
    Int J Neurosci; 2019 Oct; 129(10):963-977. PubMed ID: 30885023
    [No Abstract]   [Full Text] [Related]  

  • 2. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
    Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
    Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
    Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.
    Verbakel WF; Sauerwein W; Hideghety K; Stecher-Rasmussen F
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):743-56. PubMed ID: 12573762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
    Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
    Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
    Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
    Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
    Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron phenyl alanine targeted chitosan-PNIPAAm core-shell thermo-responsive nanoparticles: boosting drug delivery to glioblastoma in BNCT.
    Soleimanbeigi M; Dousti F; Hassanzadeh F; Mirian M; Varshosaz J; Kasesaz Y; Rostami M
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1607-1623. PubMed ID: 35060826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron capture therapy of primary and metastatic brain tumors.
    Barth RF; Soloway AH
    Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy for glioblastoma.
    Yamamoto T; Nakai K; Matsumura A
    Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT; Capala J; Roslin M; Henriksson R
    J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
    H-Stenstam B
    Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
    [No Abstract]   [Full Text] [Related]  

  • 17. Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.
    Gilbert B; Perfetti L; Fauchoux O; Redondo J; Baudat PA; Andres R; Neumann M; Steen S; Gabel D; Mercanti D; Ciotti MT; Perfetti P; Margaritondo G; De Stasio G
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Jul; 62(1 Pt B):1110-8. PubMed ID: 11088567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
    Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP).
    Nishimura K; Kashiwagi H; Morita T; Fukuo Y; Okada S; Miura K; Matsumoto Y; Sugawara Y; Enomoto T; Suzuki M; Nakai K; Kawabata S; Nakamura H
    J Control Release; 2023 Aug; 360():249-259. PubMed ID: 37356755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.